Diese Präsentation wurde erfolgreich gemeldet.
Wir verwenden Ihre LinkedIn Profilangaben und Informationen zu Ihren Aktivitäten, um Anzeigen zu personalisieren und Ihnen relevantere Inhalte anzuzeigen. Sie können Ihre Anzeigeneinstellungen jederzeit ändern.

Gullain barre syndrome

common cause of areflexic flaccid type of weakness preceded by some infection

  • Loggen Sie sich ein, um Kommentare anzuzeigen.

Gullain barre syndrome

  1. 1. Dr Bhupendra Shah Assistant Professor Department of internal Medicine B.P .Koirala institute of Health Sciences
  2. 2. History of Gullainn-Barre syndrome
  3. 3. Leading cause of acute flaccid paralysis in developed countries Ventilation in 25% cases Death in 4-15% cases Gullain-Barre Syndrome
  4. 4. Leading cause of acute flaccid paralysis in developed countries Ventilation in 25% cases Death in 4-15%
  5. 5. Delayed transmission through injured nerve
  6. 6. Clinical Features Muscle weakness usually in the legs -Acute -Progressive -symmetric -usually peak by 2 weeks Facial weakness Dysautonomia Respiratory failure Sensory deficit:minimal bladder /bowel:transiently involved
  7. 7. Why patient die in Gullain- Barre syndrome
  8. 8. Variants of GBS Acute inflammatory demylinating polyneuropthy • Acute motor axonal neuropathy Acute motor sensory axonal neuropathy • Miller Fisher variant
  9. 9. Investigation Lumbar puncture Nerve conduction velocity CSF Analysis -cell count :normal -Protein: elevated Shows slowed nerve conduction velocity and prolonged distal latency
  10. 10. Brighton criteria 1.Bilateral and flaccid weakness of the limbs 2.Decreased /absent DTR in weak limbs. 3.Monophasic ,interval between onset and nadir of weakness between 12 h and 28 days . 4.Electrophysiological study consistent with GBS. 5.CSF:cytoalbuminologic dissociation 6. Absence of alternatice diagnosis for weakness.
  11. 11. Diagnosis certainity • 1+2+3+4+5+6:level 1 • 1+2+3+4/5+6:level 2 • 1+2+3+6:level 3
  12. 12. Treatment • Setting : usuallly Intensive care unit
  13. 13. Treatment options Immunoglobin(2g/kg:total dose) Plasmaparesis(50ml/kg/session)
  14. 14. • Force vital capacity<20ml/kg • Max.inspiratory pressure:<30cm H20 • Max Inspiratory pressure:<40 cm H20
  15. 15. Thank you

×